A phase III study of Angiomax (bivalirudin) in patients with HIT/HITTS type II undergoing cardiac surgery on cardiopulmonary bypass (CPB).

Trial Profile

A phase III study of Angiomax (bivalirudin) in patients with HIT/HITTS type II undergoing cardiac surgery on cardiopulmonary bypass (CPB).

Completed
Phase of Trial: Phase III

Latest Information Update: 08 Nov 2011

At a glance

  • Drugs Bivalirudin (Primary)
  • Indications Thrombosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 08 Nov 2011 Actual end date (Oct 2005) added as reported by ClinicalTrials.gov.
    • 08 Jul 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 30 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top